Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Casi Pharmaceuticals Inc (CASI)

Casi Pharmaceuticals Inc (CASI)
2.0100 +0.0900 (+4.69%) 11:58 ET [NASDAQ]
1.9600 x 1 2.1500 x 15
Realtime by (Cboe BZX)
1.9600 x 1 2.1500 x 15
Realtime - - (-) -
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.9900
Day High
2.0100
Open 2.0100
Previous Close 1.9200 1.9200
Volume 5,940 5,940
Avg Vol 15,072 15,072
Stochastic %K 14.13% 14.13%
Weighted Alpha -48.09 -48.09
5-Day Change -0.0875 (-4.17%) -0.0875 (-4.17%)
52-Week Range 1.8800 - 7.6700 1.8800 - 7.6700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,614
  • Shares Outstanding, K 12,299
  • Annual Sales, $ 28,540 K
  • Annual Income, $ -39,260 K
  • EBIT $ -39 M
  • EBITDA $ -37 M
  • 60-Month Beta 0.66
  • Price/Sales 0.84
  • Price/Cash Flow N/A
  • Price/Book 16.23

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 78.33%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.61
  • Number of Estimates 1
  • High Estimate -0.61
  • Low Estimate -0.61
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +14.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8800 +6.91%
on 04/10/25
Period Open: 2.2140
2.5227 -20.32%
on 03/25/25
-0.2040 (-9.21%)
since 03/21/25
3-Month
1.8800 +6.91%
on 04/10/25
Period Open: 2.5800
2.7900 -27.96%
on 01/24/25
-0.5700 (-22.09%)
since 01/22/25
52-Week
1.8800 +6.91%
on 04/10/25
Period Open: 2.4300
7.6700 -73.79%
on 09/11/24
-0.4200 (-17.28%)
since 04/22/24

Most Recent Stories

More News
CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish

The company said that its special committee of the board of directors will evaluate the proposed transaction.

CASI : 2.0100 (+4.69%)
CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

BEIJING, CN / ACCESS Newswire / April 3, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics...

CASI : 2.0100 (+4.69%)
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing...

CASI : 2.0100 (+4.69%)
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and...

CASI : 2.0100 (+4.69%)
Nasdaq Futures Fall as Micron’s Sales Outlook Disappoints, U.S. GDP Data and Nike Earnings in Focus

September Nasdaq 100 E-Mini futures (NQU24) are trending down -0.23% this morning as an underwhelming sales forecast from chipmaker Micron weighed on sentiment, while investors awaited a flurry of U.S....

WHR : 77.67 (+0.82%)
AAPL : 200.80 (+3.96%)
HMB.S.DX : 142.100 (+1.79%)
MKC : 75.75 (+1.45%)
NQU24 : 19,808.01s (-0.21%)
USB : 38.71 (+2.38%)
IP : 46.36 (+2.89%)
MU : 69.70 (+4.44%)
NKE : 57.89 (+3.15%)
CASI : 2.0100 (+4.69%)
LEVI : 15.59 (+3.79%)
AYI : 233.07 (+1.87%)
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

CASI : 2.0100 (+4.69%)
Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

CASI : 2.0100 (+4.69%)
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing...

CASI : 2.0100 (+4.69%)
CASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI) ("CASI" or the "Company"), a biopharmaceutical company focused on developing and commercializing...

CASI : 2.0100 (+4.69%)
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative...

CASI : 2.0100 (+4.69%)

Business Summary

CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic...

See More

Key Turning Points

3rd Resistance Point 2.3867
2nd Resistance Point 2.2933
1st Resistance Point 2.1067
Last Price 2.0100
1st Support Level 1.8267
2nd Support Level 1.7333
3rd Support Level 1.5467

See More

52-Week High 7.6700
Fibonacci 61.8% 5.4582
Fibonacci 50% 4.7750
Fibonacci 38.2% 4.0918
Last Price 2.0100
52-Week Low 1.8800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro